We are live on ! Find out more
BCM

BluePath Capital Management Portfolio holdings

AUM $182M
1-Year Est. Return 38.9%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+38.9%
3 Year Est. Return
+101.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
+$24.1M
Cap. Flow
+$22.1M
Cap. Flow %
11.89%
Top 10 Hldgs %
52.67%
Holding
111
New
9
Increased
75
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
GIAX
Nicholas Global Equity and Income ETF
GIAX
+$11.9M
2
FIAX icon
Nicholas Fixed Income Alternative ETF
FIAX
+$4.95M
3
MU icon
Micron Technology
MU
+$1.09M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.02M
5
AMD icon
Advanced Micro Devices
AMD
+$899K

Top Sells

Rank Stock Value
1
ZHDG icon
Zega Buy & Hedge ETF
ZHDG
+$5.93M
2
MRK icon
Merck
MRK
+$957K
3
ON icon
ON Semiconductor
ON
+$813K
4
UNH icon
UnitedHealth
UNH
+$772K
5
MCK icon
McKesson
MCK
+$682K

Sector Composition

Rank Sector Weight
1 Technology 15.51%
2 Financials 10.59%
3 Consumer Discretionary 8.66%
4 Consumer Staples 4.91%
5 Industrials 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAK
101
Northern Dynasty Minerals
NAK
$812M
$13.5K 0.01%
20,300
– –
FCEL icon
102
FuelCell Energy
FCEL
$1.58B
– –
-483
Closed -$5.51K
ICE icon
103
Intercontinental Exchange
ICE
$86.2B
– –
-1,356
Closed -$218K
IEX icon
104
IDEX
IEX
$16.6B
– –
-974
Closed -$209K
MCD icon
105
McDonald's
MCD
$194B
– –
-702
Closed -$214K
MCK icon
106
McKesson
MCK
$103B
– –
-1,379
Closed -$682K
MINT icon
107
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
– –
-2,360
Closed -$238K
MRK icon
108
Merck
MRK
$325B
– –
-8,426
Closed -$957K
ON icon
109
ON Semiconductor
ON
$32.9B
– –
-11,196
Closed -$813K
TMO icon
110
Thermo Fisher Scientific
TMO
$212B
– –
-389
Closed -$241K
AXNX
111
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-3,786
Closed -$264K
1 2 3 4
5

Similar funds

MAM
MWA Asset Management Lexington, Massachusetts $183M AUM 41.7% 1-Year Est. Return
WA
WESPAC Advisors Orinda, California $183M AUM 29.81% 1-Year Est. Return
ACG
Ampersand Capital Group Burlingame, California $183M AUM 3.46% 1-Year Est. Return
CF
Claris Financial Glen Allen, Virginia $183M AUM 17.41% 1-Year Est. Return
QC
Quantedge Capital Singapore $183M AUM 37.27% 1-Year Est. Return
RS
R Squared Central, Hong Kong $182M AUM 18.52% 1-Year Est. Return
SPI
Sutton Place Investors Katonah, New York $183M AUM 19.55% 1-Year Est. Return
NED
Nancy E. Dempze $182M AUM 16.09% 1-Year Est. Return

BluePath Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, BluePath Capital Management held 111 positions worth $186M, up 15% from $162M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

BluePath Capital Management deployed $22.1M of net new capital in Q4 2024, opening 9 new positions and adding to 75 existing holdings. Its largest new stake was Micron Technology: 10,710 shares worth $1.02M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Zega Buy & Hedge ETF, an estimated $5.93M trimmed.

  • BluePath Capital Management's largest Q4 2024 buy was Micron Technology: 10,710 shares worth $1.02M.
  • BluePath Capital Management added most to Nicholas Global Equity and Income ETF in Q4 2024, an estimated $11.9M increase.
  • BluePath Capital Management's biggest Q4 2024 reduction was Zega Buy & Hedge ETF, cutting an estimated $5.93M.
  • BluePath Capital Management fully exited Merck in Q4 2024, selling an estimated $957K.
  • BluePath Capital Management's ten largest holdings make up 53% of its $186M portfolio in Q4 2024.
  • BluePath Capital Management opened 9 new positions and closed 10 in Q4 2024.
  • BluePath Capital Management's portfolio value rose 15% quarter-over-quarter to $186M.

Based on BluePath Capital Management's 13F filing for Q4 2024, filed 14 Jan 2025.